NKTR logo

Nektar Therapeutics (NKTR) Total Debt

Annual Total Debt:

$194.34M-$36.06M(-15.65%)
December 31, 2024

Summary

  • As of today, NKTR annual total debt is $194.34 million, with the most recent change of -$36.06 million (-15.65%) on December 31, 2024.
  • During the last 3 years, NKTR annual total debt has fallen by -$96.95 million (-33.28%).
  • NKTR annual total debt is now -56.90% below its all-time high of $450.92 million, reached on December 31, 2019.

Performance

NKTR Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRbalance sheet metrics

Quarterly Total Debt:

$176.73M-$9.93M(-5.32%)
June 30, 2025

Summary

  • As of today, NKTR quarterly total debt is $176.73 million, with the most recent change of -$9.93 million (-5.32%) on June 30, 2025.
  • Over the past year, NKTR quarterly total debt has dropped by -$42.88 million (-19.52%).
  • NKTR quarterly total debt is now -63.28% below its all-time high of $481.24 million, reached on March 31, 2020.

Performance

NKTR Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRbalance sheet metrics

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

NKTR Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-15.7%-19.5%
3Y3 Years-33.3%-44.1%
5Y5 Years-56.9%-21.5%

NKTR Total Debt Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-33.3%at low-41.1%at low
5Y5-Year-56.9%at low-48.8%at low
All-TimeAll-Time-56.9%>+9999.0%-63.3%>+9999.0%

NKTR Total Debt History

DateAnnualQuarterly
Jun 2025
-
$176.73M(-5.3%)
Mar 2025
-
$186.66M(-4.0%)
Dec 2024
$194.34M(-15.7%)
$194.34M(-5.7%)
Sep 2024
-
$206.09M(-6.2%)
Jun 2024
-
$219.61M(-5.3%)
Mar 2024
-
$231.94M(+0.7%)
Dec 2023
$230.40M(-10.7%)
$230.40M(-5.9%)
Sep 2023
-
$244.90M(-6.0%)
Jun 2023
-
$260.41M(-4.7%)
Mar 2023
-
$273.29M(+5.9%)
Dec 2022
$257.96M(-11.4%)
$257.96M(-14.1%)
Sep 2022
-
$300.25M(-5.1%)
Jun 2022
-
$316.24M(-3.5%)
Mar 2022
-
$327.84M(+12.5%)
Dec 2021
$291.29M(-9.1%)
$291.29M(-11.3%)
Sep 2021
-
$328.22M(-2.5%)
Jun 2021
-
$336.51M(-2.6%)
Mar 2021
-
$345.46M(+7.8%)
Dec 2020
$320.36M(-29.0%)
$320.36M(+45.1%)
Sep 2020
-
$220.75M(-1.9%)
Jun 2020
-
$225.06M(-53.2%)
Mar 2020
-
$481.24M(+6.7%)
Dec 2019
$450.92M(+46.1%)
$450.92M(-5.3%)
Sep 2019
-
$476.13M(+12.2%)
Jun 2019
-
$424.20M(-0.2%)
Mar 2019
-
$424.90M(+37.7%)
Dec 2018
$308.67M(-3.8%)
$308.67M(-7.0%)
Sep 2018
-
$331.92M(-0.9%)
Jun 2018
-
$334.94M(-1.0%)
Mar 2018
-
$338.49M(+5.5%)
Dec 2017
$320.99M(-4.1%)
$320.99M(-7.3%)
Sep 2017
-
$346.17M(-1.1%)
Jun 2017
-
$350.00M(-0.7%)
Mar 2017
-
$352.35M(+5.2%)
Dec 2016
$334.83M(-2.4%)
$334.83M(-6.1%)
Sep 2016
-
$356.41M(-1.1%)
Jun 2016
-
$360.53M(-1.2%)
Mar 2016
-
$364.87M(+5.3%)
Dec 2015
$342.94M(+47.0%)
$346.36M(+36.7%)
Sep 2015
-
$253.37M(-0.8%)
Jun 2015
-
$255.50M(-0.3%)
Mar 2015
-
$256.36M(+9.9%)
Dec 2014
$233.23M(-10.8%)
$233.23M(-7.0%)
Sep 2014
-
$250.83M(-0.6%)
Jun 2014
-
$252.46M(-0.3%)
Mar 2014
-
$253.18M(-3.2%)
Dec 2013
$261.57M(+91.5%)
$261.57M(+95.2%)
Sep 2013
-
$134.01M(-0.7%)
Jun 2013
-
$134.90M(-0.6%)
Mar 2013
-
$135.77M(-0.6%)
Dec 2012
$136.61M(-41.1%)
$136.61M(-48.3%)
Sep 2012
-
$264.16M(+15.8%)
Jun 2012
-
$228.13M(-0.3%)
Mar 2012
-
$228.84M(-1.3%)
Dec 2011
$231.97M(0.0%)
$231.97M(+0.8%)
Sep 2011
-
$230.21M(-0.3%)
Jun 2011
-
$230.82M(-0.3%)
Mar 2011
-
$231.40M(-0.2%)
Dec 2010
$231.97M(-0.8%)
$231.97M(-0.2%)
Sep 2010
-
$232.36M(-0.2%)
Jun 2010
-
$232.84M(-0.2%)
Mar 2010
-
$233.31M(-0.2%)
Dec 2009
$233.75M
$233.75M(-0.2%)
DateAnnualQuarterly
Sep 2009
-
$234.18M(-0.2%)
Jun 2009
-
$234.57M(-0.2%)
Mar 2009
-
$234.94M(-0.2%)
Dec 2008
$235.30M(-30.6%)
$235.30M(-30.2%)
Sep 2008
-
$337.09M(-0.2%)
Jun 2008
-
$337.85M(-0.2%)
Mar 2008
-
$338.59M(-0.1%)
Dec 2007
$338.97M(-22.6%)
$338.97M(-16.3%)
Sep 2007
-
$404.75M(+0.7%)
Jun 2007
-
$401.77M(-0.0%)
Mar 2007
-
$401.94M(-8.3%)
Dec 2006
$438.12M(-0.4%)
$438.12M(+0.0%)
Sep 2006
-
$438.07M(-0.0%)
Jun 2006
-
$438.19M(-0.0%)
Mar 2006
-
$438.30M(-0.3%)
Dec 2005
$439.78M(+120.9%)
$439.78M(+0.3%)
Sep 2005
-
$438.52M(+125.0%)
Jun 2005
-
$194.89M(-0.7%)
Mar 2005
-
$196.30M(-1.4%)
Dec 2004
$199.06M(-49.4%)
$199.06M(-0.1%)
Sep 2004
-
$199.35M(-3.2%)
Jun 2004
-
$205.89M(-4.0%)
Mar 2004
-
$214.52M(-45.5%)
Dec 2003
$393.30M(+18.5%)
$393.30M(-7.5%)
Sep 2003
-
$424.98M(+3.5%)
Jun 2003
-
$410.81M(+23.9%)
Mar 2003
-
$331.70M(-0.1%)
Dec 2002
$332.02M(+0.0%)
$332.02M(-0.1%)
Sep 2002
-
$332.45M(+0.2%)
Jun 2002
-
$331.86M(+0.1%)
Mar 2002
-
$331.68M(-0.1%)
Dec 2001
$331.87M(+3.6%)
$331.87M(+0.6%)
Sep 2001
-
$329.74M(+1.0%)
Jun 2001
-
$326.46M(+2.4%)
Mar 2001
-
$318.92M(-0.4%)
Dec 2000
$320.29M(+182.5%)
$320.29M(+32.0%)
Sep 2000
-
$242.63M(-0.0%)
Jun 2000
-
$242.64M(-0.8%)
Mar 2000
-
$244.65M(+115.8%)
Dec 1999
$113.39M(+2166.0%)
$113.39M(+2212.2%)
Sep 1999
-
$4.90M(-0.3%)
Jun 1999
-
$4.92M(>+9900.0%)
Mar 1999
-
$0.00(-100.0%)
Dec 1998
$5.00M(-3.5%)
$5.00M(+0.9%)
Sep 1998
-
$4.96M(-0.3%)
Jun 1998
-
$4.97M(-2.2%)
Mar 1998
-
$5.09M(-1.9%)
Dec 1997
$5.18M(+1368.8%)
$5.18M(+3403.4%)
Sep 1997
-
$148.00K(-8.6%)
Jun 1997
-
$162.00K(-7.4%)
Mar 1997
-
$175.00K(-56.3%)
Dec 1996
$353.00K(-41.0%)
$400.00K(+100.0%)
Sep 1996
-
$200.00K(-33.3%)
Jun 1996
-
$300.00K(0.0%)
Mar 1996
-
$300.00K(-50.0%)
Dec 1995
$598.00K(-12.6%)
$600.00K(+100.0%)
Sep 1995
-
$300.00K(0.0%)
Jun 1995
-
$300.00K(-25.0%)
Mar 1995
-
$400.00K(-42.9%)
Dec 1994
$684.00K
$700.00K(+250.0%)
Sep 1994
-
$200.00K(-75.0%)
Jun 1994
-
$800.00K(0.0%)
Mar 1994
-
$800.00K

FAQ

  • What is Nektar Therapeutics annual total debt?
  • What is the all-time high annual total debt for Nektar Therapeutics?
  • What is Nektar Therapeutics annual total debt year-on-year change?
  • What is Nektar Therapeutics quarterly total debt?
  • What is the all-time high quarterly total debt for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly total debt year-on-year change?

What is Nektar Therapeutics annual total debt?

The current annual total debt of NKTR is $194.34M

What is the all-time high annual total debt for Nektar Therapeutics?

Nektar Therapeutics all-time high annual total debt is $450.92M

What is Nektar Therapeutics annual total debt year-on-year change?

Over the past year, NKTR annual total debt has changed by -$36.06M (-15.65%)

What is Nektar Therapeutics quarterly total debt?

The current quarterly total debt of NKTR is $176.73M

What is the all-time high quarterly total debt for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly total debt is $481.24M

What is Nektar Therapeutics quarterly total debt year-on-year change?

Over the past year, NKTR quarterly total debt has changed by -$42.88M (-19.52%)
On this page